Barry Iacopetta - Concepedia

Author

Barry Iacopetta

Also Known As

B Iacopetta, B J Iacopetta, B. J. Iacopetta, B.J. Iacopetta, Barry IACOPETTA, Barry Iacopetta, Barry J Iacopetta, Barry J. Iacopetta, Diaz-Cano, Salvador J., IACOPETTA BJ

164

Publications

12.6K

Citations

H-Index

112

Concepts

All Affiliations

The University of Western Australia Sir Charles Gairdner Hospital National University of Singapore National University Cancer Institute, Singapore St John of God Subiaco Hospital

About

Barry Iacopetta is an author at The University of Western Australia specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	54	5K
2	Health Sciences	6	6	362
3	Natural Sciences	5	5	721
4	Engineering	2	2	110
5	Law	1	1	23

Barry Iacopetta

107

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Tumor-Infiltrating FOXP3 <sup>+</sup> T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer Paul Salama, Michael Phillips, Fabienne Grieu, Journal of Clinical Oncology	2008	962
Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR Nirosha Suraweera, Alex Duval, Maryline Répérant, Gastroenterology Pentaplex PcrGenome InstabilityTumor HeterogeneityMedicineGenetics	2002	605
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer Hany Elsaleh, David Joseph, Fabienne Grieu, The Lancet Surgical OncologyCancer EpidemiologyGastrointestinal OncologyMedicineCancer Management	2000	556
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Marius van Rijnsoever, Hany Elsaleh, David Joseph, PubMed	2003	268
The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes. Barry Iacopetta, Evan H. Morgan Journal of Biological Chemistry Apparent Activation EnergyRabbit ReticulocytesIron MetabolismCytoskeletonCellular Physiology	1983	225
P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Hany Elsaleh, Brenda L. Powell, Kieran McCaul, PubMed	2001	206
PIK3CA mutations in breast cancer are associated with poor outcome Shaoying Li, Minna Rong, Fabienne Grieu, Breast Cancer Research and Treatment Tumor BiologyBreast OncologyCancer PathologyMedicinePathology	2005	206
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study Jervoise Andreyev, A. R. Norman, David Cunningham, British Journal of Cancer	2001	204
Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site Sylvia Rothenberger, Barry Iacopetta, Lukas C. Kühn Cell Signal TransductionMedicineNatural SciencesPhosphorylation SiteCytoplasmic Domain	1987	193
BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status Wei Qi Li, Kazuyuki Kawakami, Andrew Ruszkiewicz, Molecular Cancer	2006	179

Page 1